11 – 20 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Cerebrospinal fluid biomarker levels: Total tau and phosphorylated tau as markers for rate of progression in Alzheimer’s disease.
2018) Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting 2018(
- Contribution to conference › Abstract
-
Mark
Economic Evaluation of Interventions for Screening of Dementia
2018) In Working Papers(
- Working paper/Preprint › Working paper
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement
(
- Contribution to journal › Article
-
Mark
Use of flutemetamol F18-labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Economic Evaluation of Nonpharmacological Interventions for Dementia Patients and their Caregivers - A Systematic Literature Review
2018) In Working Papers(
- Working paper/Preprint › Working paper
-
Mark
Psychosocial behaviour management programme for home-dwelling people with dementia : A cluster-randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Dementia behaviour management programme at home : impact of a palliative care approach on care managers and professional caregivers of home care services
(
- Contribution to journal › Article
- 2017
-
Mark
Levels of cerebrospinal fluid biomarkers total tau and phosphorylated tau do not predict survival time after diagnosis of Alzheimer’s disease – An 18-year follow-up.
2017) 10th Clinical Trials Conference on Alzheimer’s Disease(
- Contribution to conference › Poster
-
Mark
The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer’s disease
(
- Contribution to journal › Article